Weekly Digest – October 2026 Weekly Digest – October 2026 28 September 2026: AstraZeneca announced an equity investment and clinical collaboration with Summit Therapeutics to advance ADC combinations in cancer AstraZeneca announced a US$2 billion strategic equity investment in Summit […]
Weekly Digest – October 2026 Weekly Digest – October 2026 29 September 2026: Nurix Therapeutics announced a $7 million milestone achievement under its strategic collaboration with Pfizer Nurix Therapeutics announced the achievement of a US$7 million research milestone under its […]
Weekly Digest – October 2026 Weekly Digest – October 2026 01 October 2026: Dong-A ST and Galux entered a research collaboration to develop AI-designed antibodies for ADC therapeutics Dong-A ST and Galux announced a research collaboration to develop novel ADC […]
Weekly Digest – September 2026 Weekly Digest – September 2026 21 September 2026: Telix and ITM join forces to create a radiopharmaceutical powerhouse Telix Pharmaceuticals announced a strategic agreement to merge with ITM Isotope Technologies Munich, creating a vertically integrated […]
Weekly Digest – September 2026 Weekly Digest – September 2026 22 September 2026: BoomRay enters exclusive global license agreement with Novartis for a novel radioligand therapy asset BoomRay announced an exclusive global license agreement with Novartis for a novel preclinical […]
Weekly Digest – September 2026 Weekly Digest – September 2026 16 September 2026: Escugen and Sovran expand collaboration to co-develop a novel bispecific ADC Escugen and Sovran Bio have entered into an agreement to co-develop a first-in-class, pan-tumor bispecific ADC, […]
Weekly Digest – September 2026 Weekly Digest – September 2026 09 September 2026: Adagene announced a milestone with Exelixis supporting the advancement of SAFEbody ADC candidates Adagene announced that it has achieved a milestone under its collaboration and license agreement […]
Weekly Digest – September 2026 Weekly Digest – September 2026 08 September 2026: Cellbion and AHN-GOOK Pharmaceutical announced a collaboration for the joint development of next-generation radiopharmaceuticals Cellbion and AHN-GOOK Pharmaceutical announced a memorandum of understanding to jointly research and […]
Weekly Digest – September 2026 Weekly Digest – September 2026 08 September 2026: ITM and SpiroChem announced a strategic discovery collaboration to expand ITM’s radiopharmaceutical pipeline ITM Isotope Technologies Munich and SpiroChem announced a strategic drug discovery collaboration to advance […]
Weekly Digest – September 2026 Weekly Digest – September 2026 01 September 2026: SYS6010 granted BTD by the NMPA in China for the treatment of patients with recurrent or metastatic HNSCC CSPC Pharmaceutical Group announced that SYS6010 has received Breakthrough […]
